Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
03/2004
03/11/2004US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease
03/11/2004DE10240603A1 Verwendung von Malat-Dehydrogenase zur NADH-Regenerierung Use of malate dehydrogenase for NADH regeneration
03/11/2004CA2497597A1 Methods for identifying subjects at risk of melanoma and treatments
03/11/2004CA2497047A1 Adzymes and uses thereof
03/11/2004CA2496789A1 Methods for preserving organs and tissues
03/11/2004CA2496745A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor
03/11/2004CA2495295A1 Group b streptococcal phage lysin
03/11/2004CA2495212A1 Analytical method for the determination of infant formula protein digestibility in vitro
03/10/2004EP1396545A1 Cell cycle regulatory factor
03/10/2004EP1396544A1 Nucleic acids encoding human thyroid dehalogenases
03/10/2004EP1396542A2 Novel P-selectin ligand protein
03/10/2004EP1396537A1 Treatment of elevated plasma homocysteine
03/10/2004EP1395758A1 Axial load-insensitive emergency bearing
03/10/2004EP1395674A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/10/2004EP1395666A1 Protease deficient caulobacter host cells
03/10/2004EP1395656A2 Human drug metabolizing enzymes
03/10/2004EP1395654A1 Regulation of human zinc carboxypeptidase b-like protein
03/10/2004EP1395653A2 Polypeptides having cellobiase activity and polynucleotides encoding same
03/10/2004EP1395530A1 Process for the preparation of amorphous cilastatin sodium
03/10/2004EP1395419A1 Preservation of biological materials using fiber-forming techniques
03/10/2004EP1395293A1 Lentiviral vectors encoding clotting factors for gene therapy
03/10/2004EP1395291A2 Novel nucleic acids and their therapeutic use in ophthalmology
03/10/2004EP1234043B1 Constructs for delivery of therapeutic agents to neuronal cells
03/10/2004CN1481439A Method for prodn. of heterologous protein by fungus
03/10/2004CN1481438A Method for preparing vitamin K-dependence protein
03/10/2004CN1480529A High yield fungus for alkali pectinase and screen method as well as ferentation method for producing alkali pectinase by using the strain
03/10/2004CN1480466A Interfusion protein possessing dual functions of thrombolysis and anticoagulation as well as its application
03/10/2004CN1141389C Method for producing recombinant glucokinase
03/10/2004CN1141388C Prepn. and application of properly cooled proteinase with special flavor
03/10/2004CN1141387C Novel PPGPP synthetase and expression systems for improved production of protein of interest
03/09/2004US6703542 Polyphenol oxidase genes
03/09/2004US6703541 Nematode inducible promoter sequence from maize inbred line mp307, and dna constructs
03/09/2004US6703540 Transformation of host cells with a nucleic acid encoding a nonheme haloperoxidase; enhanced resistance to phytopathogens
03/09/2004US6703484 Generating prferential polypeptides; obtain cells, transform with expression vector, culture cell, recover preferential polypeptides
03/09/2004US6703230 47174, a novel human glycosyltransferase and uses thereof
03/09/2004US6703229 Aryl propenal double bond reductase
03/09/2004US6703223 Fermentation; corynebacterium
03/09/2004US6703218 Process for the preparation of linalool oxide or of linalool oxide-containing mixtures
03/09/2004US6703216 Methods, compositions and apparatuses for detection of gamma-hydroxybutyric acid (GHB)
03/09/2004US6703215 Detecting preferential enzyme inhibitor; obtain substrate, incubate with enzyme mixture, expose to enzyme inhibitor, monitor for decrease in enzymatic activity
03/09/2004US6703213 Substrate analogs for MurG, methods of making same and assays using same
03/09/2004US6702705 Prodrugs activated by targeted catalytic proteins
03/04/2004WO2004018695A2 Method for producing ketocarotinoids in plant fruit
03/04/2004WO2004018694A2 Method for producing ketocarotinoids in genetically modified organisms
03/04/2004WO2004018693A2 Method for the production of ketocarotinoids in flower petals on plants
03/04/2004WO2004018688A1 Method for the production of $g(b)-carotinoids
03/04/2004WO2004018687A2 Nucleic acid sequences encoding proteins associated with abiotic stress response
03/04/2004WO2004018682A1 Novel glycosyltransferase genes
03/04/2004WO2004018672A1 NOVEL ALDOLASES AND PROCESS FOR PRODUCING SUBSTITUTED α-KETO ACID
03/04/2004WO2004018669A1 Salt-inducible kinases 2 and use thereof
03/04/2004WO2004018666A1 Expression vectors encoding epitopes of target-associated antigens
03/04/2004WO2004018662A2 Cellulases and hemicellulases and uses thereof
03/04/2004WO2004018661A1 Regulation of human esterase-like protein
03/04/2004WO2004018660A2 Novel lipases and uses thereof
03/04/2004WO2004018645A2 Utilization of starch products for biological production by fermentation
03/04/2004WO2004018641A2 Kinases and phosphatases
03/04/2004WO2004018634A2 Polynucleotide encoding oxalate decarboxylase from aspergillus niger and methods of use
03/04/2004WO2004018632A2 High-throughput screen for modulators of chromatin modifying activity
03/04/2004WO2004018620A2 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter
03/04/2004WO2004018510A1 Marker for cancer
03/04/2004WO2004018385A2 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof
03/04/2004WO2004018002A2 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells
03/04/2004WO2004017923A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
03/04/2004WO2004017910A2 Total synthesis of heparin
03/04/2004WO2004017909A2 Methods of reducing ischemic injury
03/04/2004WO2004017749A2 Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed
03/04/2004WO2004017728A2 Methods
03/04/2004WO2003103577A3 Novel recombinant anticoagulant proteins
03/04/2004WO2003087354A3 Novel purified polypeptides involved in nucleotide transport and metabolism
03/04/2004WO2003083052A3 Method of using anti-apoptotic factors in gene expression
03/04/2004WO2003072787A3 Method for detection of leptin receptor ligands
03/04/2004WO2003070901A3 Heat stable mutants of starch biosynthesis enzymes
03/04/2004WO2003054127A3 Subtilisin variants with improved characteristics
03/04/2004WO2003052088A3 Regulation of human sialyltransferase
03/04/2004WO2003051914A3 Ides, an igg-degrading enzyme of streptococcus pyogenes
03/04/2004WO2003047547A3 Prenyltransferase from plants
03/04/2004WO2003047527A3 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
03/04/2004WO2003040409A9 Novel germinal center kinase proteins, compositions, and methods of use
03/04/2004WO2003019198A3 Methods relating to treatment of atherosclerosis
03/04/2004WO2003019196A3 Diagnosis and treatment of atherosclerosis
03/04/2004WO2003018766A9 Self-processing plants and plant parts
03/04/2004WO2003016536A3 Plasmids from anaerocellum thermophilum and uses thereof
03/04/2004WO2003012034A9 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/04/2004WO2003008571A3 Chimeric chains that code for proteins that induce effects directed against viruses
03/04/2004WO2002099092A3 Production of recombinant human lysosomal alpha-mannosidase
03/04/2004WO2002081746A3 A method for identifying constitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof
03/04/2004WO2002072606A3 Epitope testing using hla
03/04/2004WO2002036780A8 Stearoyl-coa desaturase gene promoter
03/04/2004WO2002018430A8 Nucleotide sequences which code for the metr and metz genes
03/04/2004US20040045051 Comprises nucleotide sequences coding phytol kinase associated with vitamin e and tocotrienol biosynthesis for diagnosis, prevention and treatment of cardiovascular and cancer diseases
03/04/2004US20040044194 Aggrecanase molecules
03/04/2004US20040044191 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders
03/04/2004US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases
03/04/2004US20040044179 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/04/2004US20040043953 Genetic engineering; culture product
03/04/2004US20040043941 Antiinflamamtory agents; autoimmune disease; anticancer agents
03/04/2004US20040043929 Novel proteins and nucleic acids encoding same
03/04/2004US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders
03/04/2004US20040043923 Detection, calibration binding of ligand to nucleic acids
03/04/2004US20040043470 Regulation of human histone deacetylase